90 related articles for article (PubMed ID: 16796526)
21. Inhibition of HIV entry by carbohydrate-binding proteins.
Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
[TBL] [Abstract][Full Text] [Related]
22. Targeting HIV entry through interaction with envelope glycoprotein 120 (gp120): synthesis and antiviral evaluation of 1,3,5-triazines with aromatic amino acids.
Lozano V; Aguado L; Hoorelbeke B; Renders M; Camarasa MJ; Schols D; Balzarini J; San-Félix A; Pérez-Pérez MJ
J Med Chem; 2011 Aug; 54(15):5335-48. PubMed ID: 21749165
[TBL] [Abstract][Full Text] [Related]
23. Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression.
Nabatov AA; van Montfort T; Geijtenbeek TB; Pollakis G; Paxton WA
FEBS J; 2006 Nov; 273(21):4944-58. PubMed ID: 17010165
[TBL] [Abstract][Full Text] [Related]
24. The calcium-induced conformation and glycosylation of scavenger-rich cysteine repeat (SRCR) domains of glycoprotein 340 influence the high affinity interaction with antigen I/II homologs.
Purushotham S; Deivanayagam C
J Biol Chem; 2014 Aug; 289(32):21877-87. PubMed ID: 24923446
[TBL] [Abstract][Full Text] [Related]
25. The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system.
Sarrias MR; Grønlund J; Padilla O; Madsen J; Holmskov U; Lozano F
Crit Rev Immunol; 2004; 24(1):1-37. PubMed ID: 14995912
[TBL] [Abstract][Full Text] [Related]
26. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
27. A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin.
Leito JT; Ligtenberg AJ; Nazmi K; de Blieck-Hogervorst JM; Veerman EC; Nieuw Amerongen AV
Biol Chem; 2008 Sep; 389(9):1193-200. PubMed ID: 18713006
[TBL] [Abstract][Full Text] [Related]
28. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
29. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
[TBL] [Abstract][Full Text] [Related]
30. Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4.
Hashimoto C; Nomura W; Narumi T; Fujino M; Tsutsumi H; Haseyama M; Yamamoto N; Murakami T; Tamamura H
ChemMedChem; 2013 Oct; 8(10):1668-72. PubMed ID: 24039179
[TBL] [Abstract][Full Text] [Related]
31. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
[TBL] [Abstract][Full Text] [Related]
32. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
Mori T; Boyd MR
Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
[TBL] [Abstract][Full Text] [Related]
33. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
[TBL] [Abstract][Full Text] [Related]
34. Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.
Mondor I; Moulard M; Ugolini S; Klasse PJ; Hoxie J; Amara A; Delaunay T; Wyatt R; Sodroski J; Sattentau QJ
Virology; 1998 Sep; 248(2):394-405. PubMed ID: 9721247
[TBL] [Abstract][Full Text] [Related]
35. The scavenging capacity of DMBT1 is impaired by germline deletions.
Bikker FJ; End C; Ligtenberg AJM; Blaich S; Lyer S; Renner M; Wittig R; Nazmi K; van Nieuw Amerongen A; Poustka A; Veerman ECI; Mollenhauer J
Immunogenetics; 2017 Jun; 69(6):401-407. PubMed ID: 28364129
[TBL] [Abstract][Full Text] [Related]
36. Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340.
Ligtenberg TJ; Bikker FJ; Groenink J; Tornoe I; Leth-Larsen R; Veerman EC; Nieuw Amerongen AV; Holmskov U
Biochem J; 2001 Oct; 359(Pt 1):243-8. PubMed ID: 11563989
[TBL] [Abstract][Full Text] [Related]
37. Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains.
Bikker FJ; Ligtenberg AJ; End C; Renner M; Blaich S; Lyer S; Wittig R; van't Hof W; Veerman EC; Nazmi K; de Blieck-Hogervorst JM; Kioschis P; Nieuw Amerongen AV; Poustka A; Mollenhauer J
J Biol Chem; 2004 Nov; 279(46):47699-703. PubMed ID: 15355985
[TBL] [Abstract][Full Text] [Related]
38. Identification of anti-HIV components of salivary agglutinin (SAG).
Chow BE
Penn Dent J (Phila); 2002; 102():11. PubMed ID: 15487554
[No Abstract] [Full Text] [Related]
39. Review: Gp-340/DMBT1 in mucosal innate immunity.
Madsen J; Mollenhauer J; Holmskov U
Innate Immun; 2010 Jun; 16(3):160-7. PubMed ID: 20418254
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of adociavirin, a novel HIV-inhibitory protein from the sponge Adocia sp.
O'Keefe BR; Erim T; Beutler JA; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Sowder RC; Johnson DG; Buckheit RW; Halliday S; Boyd MR
FEBS Lett; 1998 Jul; 431(1):85-90. PubMed ID: 9684871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]